Stem cells are pluripotent cells with remarkable potential to develop into many different cell types in the body during early life and growth. Stem cells hold promise for regenerative medicine and cell therapy, especially in fields where more personalized medicine approaches are becoming increasingly predominant. For example, a wide variety of progenitor/stem cell therapies are recognized as a promising strategy to repair damaged tissue, such as an ischemic damaged heart. Although stem cells carry promise, there are still challenges. Current protocols for differentiating induced pluripotent stem cells (iPSCs) into mature cardiomyocytes are expensive, poorly reproducible, and limited in terms of scale-up.